Clinical trials
Active, not recruiting Prostatic Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 9 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 2 |
| 2024 | 6 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 49 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 6 |
| Eli Lilly and Company | 4 |
| Peter MacCallum Cancer Centre, Australia | 4 |
| Aragon Pharmaceuticals, Inc. | 3 |
| Pfizer | 3 |
| University of Sydney | 3 |
| Amgen | 2 |
| Janssen Research & Development, LLC | 2 |
| Novartis Pharmaceuticals | 2 |
| Royal North Shore Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 49 |
| Neoplasm Metastasis | 6 |
| Neoplasms | 6 |
| Breast Neoplasms | 5 |
| Ovarian Neoplasms | 5 |
| Uterine Cervical Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Endometrial Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Stomach Neoplasms | 3 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.